2viw: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== | ==Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator== | ||
<StructureSection load='2viw' size='340' side='right' caption='[[2viw]], [[Resolution|resolution]] 2.05Å' scene=''> | <StructureSection load='2viw' size='340' side='right' caption='[[2viw]], [[Resolution|resolution]] 2.05Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| Line 32: | Line 32: | ||
</div> | </div> | ||
<div class="pdbe-citations 2viw" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 2viw" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 47: | Line 44: | ||
[[Category: Frederickson, M]] | [[Category: Frederickson, M]] | ||
[[Category: Matthews, J E]] | [[Category: Matthews, J E]] | ||
[[Category: | [[Category: McMenamin, R]] | ||
[[Category: Smith, D]] | [[Category: Smith, D]] | ||
[[Category: Vinkovic, M]] | [[Category: Vinkovic, M]] | ||
| Line 58: | Line 55: | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Kringle]] | [[Category: Kringle]] | ||
[[Category: Pharmaceutical]] | |||
[[Category: Phosphorylation]] | [[Category: Phosphorylation]] | ||
[[Category: Plasminogen activation]] | [[Category: Plasminogen activation]] | ||
[[Category: Polymorphism]] | |||
[[Category: Protease]] | [[Category: Protease]] | ||
[[Category: Secreted]] | [[Category: Secreted]] | ||